Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03409497 · ClinicalTrials.gov registry record · NA

Effects of Grape Juice With Breakfast on Glycemia and Cognitive Function in Healthy Adults

A NA study, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT03409497 is a NA study that has completed, run by Purdue University. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03409497, a NA study, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Assess the impact of 100% grape juice with a meal on postprandial glycemic response and subsequent appetite, food intake and cognitive function.

Interventions

  • OTHER Concord Grape Juice
  • OTHER Low flavonoid beverage
  • OTHER Low flavonoid low essence beverage

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2019-05-17
Est. Completion 2020-06-30
Phase NA

Sponsor

Purdue University

141 total trials

What the Registry Record Tells You About NCT03409497

The ClinicalTrials.gov registry entry for NCT03409497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Concord Grape Juice is the first listed.

NCT03409497 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03409497 about?

NCT03409497 is a clinical study titled "Effects of Grape Juice With Breakfast on Glycemia and Cognitive Function in Healthy Adults". Assess the impact of 100% grape juice with a meal on postprandial glycemic response and subsequent appetite, food intake and cognitive function.

What is the current status of trial NCT03409497?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-05-17. Estimated completion is 2020-06-30.

What interventions are being tested in trial NCT03409497?

The interventions under investigation include: Concord Grape Juice (OTHER), Low flavonoid beverage (OTHER), Low flavonoid low essence beverage (OTHER).

Who is sponsoring clinical trial NCT03409497?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.